Diagnostic assay and reagents for detection and differentiation of polyunsaturated fatty acids
US2015196571A1
Process and composition for stabilization of vulnerable plaque utilizing a combination of a statin and omega 3 fatty acids
WO2015106177A1
Process and composition for stabilization of vulnerable plaque utilizing a combination of a statin and omega 3 fatty acids
EP2675443A1
Omega 3 fatty acid diagniostic assay for the dietary management of patients with cardiovascular disease (cvd)
CA2827579A1
Omega 3 formulations comprising epa, dha and dpa for treatment of risk factors for cardiovascular disease
CA2827577A1
A formulations comprising omega 3 fatty acids and an anti obesity agent for the reduction of body weight in cardiovascular disease patients (cvd) and diabetics
CA2827555A1
Cholesterol absorption inhibitor (azetidinone) and omega 3 fatty acids (epa, dha, dpa) for the reduction of cholesterol and for the reduction of cardiovascular events
EP2675445A1
Statin and omega 3 fatty acids (epa, dha and dpa) for use in cardiovascular diseases
